Sharps Compliance Corp

Sharps Compliance — Investor Presentation (May 2009)

22 slides from Sharps Compliance's investor presentation, May 14, 2009

  1. Slide 1: Sharps: Defining Change Through Innovation

    SHARPS Defining Change Through Innovation

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “estimate”, “anticipate”, “project” and “expect” and similar expressions are in

  3. Slide 3: Sharps Compliance Corp.

    Sharps Compliance Corp. Sharps Compliance Corp. is a fully integrated provider of cost-effective disposal solutions for medical and pharmaceutical waste generated outside the hospital setting utilizing the USPS or UPS. Our strategy is to capitalize on our leadership position and continue to penetrat

  4. Slide 4: Sharps Compliance Corp.

    Sharps Compliance Corp. NASDAQ: SMED • Market capitalization* $68.1 million • 52-week range* $5.34 - - $2.10 • Recent price* $5.28 • Total shares outstanding 12.9 million • Avg. daily trading volume (3 mos.) 12,414 • Ownership: • Institutional (estimated) 25% • Insider 60% • Fiscal Year-End June 30

  5. Slide 5: Target Markets

    Target Markets • Federal, State and Municipal Governments • Pharmaceutical Manufacturers • Hospitality • Retail Clinic • Commercial / Industrial • Professional • Agriculture • Home Infusion Distribution network, strong telesales approach & targeted Internet marketing Direct Sales: Regional and targe

  6. Slide 6: Vertically Integrated Solutions Provider

    Vertically Integrated Solutions Provider Treatment Facility Distribution Facility Data to Client Internet-based tracking system SharpsTracer™ DrugTracer™ Products in use Customer

  7. Slide 7: Vendor-Managed Inventory Solutions

    Vendor-Managed Inventory Solutions $40 million contract with an agency of the U.S. Government 6 Patient Support Programs in place with major pharmaceutical manufacturers Sharps Proprietary Medical Waste Management System (Sharps®MWMS™) ü Integrates flagship Sharps Disposal By Mail System (“SDBM”) wi

  8. Slide 8: Products and Services

    Products and Services RxTakeAway™ Medical Professional Sharps Disposal by Mail System® Sharps Secure® Sharps Disposal by Mail System®

  9. Slide 9: RxTakeAway: Convenient medication disposal solution

    RxTakeAway™ Convenient and confidential medication disposal solution Safe, eco-friendly way to protect your family, community and environment Market opportunities: Individual consumers, retail pharmacies, alternate care facilities and community programs Source: U.S. Health & Human Services 2008 Enve

  10. Slide 10: Government Regulation

    Government Regulation Sharps Disposal Legislation for Self-Injectors Source: Coalition for Safe Community Needle Disposal MAP KEY States with legislation banning trash disposal of self-injector’s sharps States interested in introducing legislation States with guidance, but do not regulate self-injec

  11. Slide 11: Financial Highlights

    Financial Highlights

  12. Slide 12: Sharps financial strengths

    SHARPS. Operating Leverage Strong Margins t Mover Advantage Early Market Penetration Recurring Revenue

  13. Slide 13: Rapid Revenue Growth

    Rapid Revenue Growth Fiscal Year Revenue (in millions) Year CAGR = 13.8% (Q3 - TTM) Revenue more than doubles in FY 2009 3 rd quarter $8.6 $9.0 $10.6 $12.0 $12.8 $16.4

  14. Slide 14: Stable Gross Margins

    Stable Gross Margins Fiscal Year Gross Margin Gross margin was 59.2% in Q3 FY 2009 Company expects gross margins to exceed 50% going forward (Q3 - TTM) 40.7% 38.9% 42.5% 41.9% 39.8% 46.4%

  15. Slide 15: Operating Leverage

    Operating Leverage Fiscal Year Operating Margin * Excludes $138,000 Q3 FY 2007 special charge (Q3 - TTM) Operating margin was 33.2% in Q3 FY 2009 Beginning to recognize the operating leverage inherent in business -0.8% -1.9% 3.6% 7.2% 0.0% 11.5% 2007*

  16. Slide 16: Bottom-line Profitability

    Bottom-line Profitability ($0.01) ($0.02) $0.02 $0.075 $0.01 $0.09 Fiscal Year Net Income (in thousands) Earnings Per Share *Excludes $138 thousand Q3 FY 2007 special charge **Excludes $1.8 million, or $0.13 per diluted share, income tax benefit recorded in Q2 FY (Q3 - TTM) -$118 $382 $920 $81 $1,25

  17. Slide 17: Strong Balance Sheet

    Strong Balance Sheet Working Capital $3.6M Shareholder Equity Growth Q3 07 vs. Q3 09 333% Line of Credit Term sheet with Bank to increase to $4.5 million $2.5M (As of and for the period ending March 31, 2009) No debt as of 3/31/09

  18. Slide 18: Strategy and Outlook

    Strategy and Outlook

  19. Slide 19: Converging Factors for Success

    Converging Factors for Success Vertical integration Own treatment, facility 37 tons per day ‘capacity ‘2 Conynige Snape Compliance Corporation 2008 SHARPS. 18

  20. Slide 20: Investment Potential

    Investment Potential Leader in all markets outside of hospital Recognized name brand Value-added products and services Consistent high-quality performance Powerful operating leverage Developing strong, nationwide customer base Vertically Integrated

  21. Slide 21: Sharps: Defining Change Through Innovation

    SHARPS Defining Change Through Innovation

  22. Slide 22: Sharps product descriptions

    + SDBM + Sharps©MWMS™ + RxTakeAway™ + Sharps Secure SHARPS. - Sharps Disposal By Mail Systeme ‘Acosteffectve and easjto-use system forte proper csposal of used needles, syrnges, and otner ‘smal quantites of bio hazardous waste. The disposal soliton is weal for maiviouals who seltnect or macicalfacit

Sharps Compliance — Investor Presentation (May 2009) on 6ix